Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a one-day suspension order for a drug license at its Gopal Nagar store in New Delhi. The regulatory action, received on May 10, 2026, follows an alleged violation of the Drugs and Cosmetics Act. The financial impact of this temporary closure is estimated to be a potential revenue loss of Rs 0.30 lacs.
Details of Regulatory Action
MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, is currently subject to a one-day suspension of its drug license for a specific retail location. The store, situated in Gopal Nagar, New Delhi, was cited by the Assistant Director of the local Drugs Control Administration. The order was formally received by the company on May 10, 2026.
Basis for Suspension
The suspension stems from alleged non-compliance with the Drugs and Cosmetics Act, 1940, specifically under Rule 65 of the governing rules established in 1945. The company is actively addressing the matter to ensure full alignment with required operational standards.
Financial Impact
While the suspension impacts the daily operations of the affected Gopal Nagar outlet, the company has characterized the financial consequences as minimal. The total projected revenue loss resulting from this one-day cessation of operations is estimated at Rs 0.30 lacs. The company remains committed to maintaining high standards of compliance across its pharmacy network.
Source: BSE
